MANDADI TILAK (EVP, Chief Technology Officer) received a stock award from CVS HEALTH CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/2/2026ACC: 0000064803-26-000040
Officer· EVP, Chief Technology Officer
Since Jul 2022
+162.35K
Net shares
Net buyer
$263.4K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
165.99K acquired · 3.63K disposed
Non-Derivative Transactions2
Common Stock (RSUs)
Direct
Shares
+22.28K
Price / share
$71.82
Trade value
$1.60M
% of position
33.6%
3/31/2026
66.27K→88.54K
Common Stock
Direct
Shares
−3.63K
Price / share
$72.49
Trade value
$263.43K
% of position
4.4%
4/1/2026
83.32K→79.68K
Total
Net shares
+18.64K
Net value
$1.34M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock (RSUs) Direct | 3/31/2026 | A · Award | +22.28K | $71.82 | $1.60M | 33.6% | 66.27K | 88.54K |
| Common Stock Direct | 4/1/2026 | F · Tax Withholding | −3.63K | $72.49 | $263.43K | 4.4% | 83.32K | 79.68K |
| Total | +18.64K | $1.34M | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
143.71K shares
Shares
+143.71K
Strike price
71.82
Held after
143.71K
Exercisable
—
3/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock143.71K shares | 3/31/2026 | A · Award | +143.71K | 71.82 | — | 143.71K |